LYMPHOMA, MANTLE-CELL
Clinical trials for LYMPHOMA, MANTLE-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for hard-to-treat blood cancers
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with lymphoma or chronic lymphocytic leukemia who had already received standard treatments. The goal was to see how safe and effective the drug is. Participation could last up to four years. The study is now comp…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New combo therapy shows promise for elderly lymphoma patients
Disease control CompletedThis study tested whether adding the drug venetoclax to standard chemotherapy (R-BAC) helps older patients with high-risk mantle cell lymphoma live longer without their cancer getting worse. The trial involved 141 patients aged 65 and older (or younger if unable to have a transpl…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy offers hope for Tough-to-Treat lymphoma
Disease control CompletedThis study looked at people with mantle cell lymphoma that had come back or stopped responding to treatment. It compared a combination of ibrutinib and rituximab against other drug pairs chosen by the doctor. The main goal was to check safety and allow those who were benefiting t…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 11, 2026 20:40 UTC